Ataraxia and MVP rebrand as The Broker Investment Group

rebranding - paints

Peter Cullum-backed Ataraxia and Minority Venture Partners are rebranding to The Broker Investment Group, Insurance Age can reveal.

CEO Dave Clapp confirmed the switch as he forecast landing at least 10 more deals in 2023.

“The Broker Investment Group tells everybody exactly what we do,” he told Insurance Age.

“It is really simple and clear to people.”

Ataraxia, which means a state of serene calmness, took minority stakes in brokers with £2m-£5m of gross written premium while MVP targeted firms with GWP of £10m or more. For those inbetween the route depended on the profile of the business.

“We are in a position now where

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

Meet the MGA feature: Arc Legal 

Arc Legal CEO Lee Taylor outlines the value in having a supportive parent of the scale of AmTrust; and why it makes sense to keep an eye on legislation and social changes in order to innovate and develop new products.

Review of the Year 2024: Markerstudy’s Gary Humphreys

Gary Humphreys, group chief underwriting officer at Markerstudy, hails the completion of the Atlanta deal, dreams of having the MGA’s brand adorn the Tottenham Hotspur Stadium and mulls sitting on the sofa and doing Channel 4’s Gogglebox.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: